KLRS
Kalaris Therapeutics, Inc.
3.10$
-3.7%
vs. previous close
Closing price · As of: Sep 23, 2026
Statements
Cash Flow
Kalaris Therapeutics, Inc. (KLRS) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Operating Cash Flow" came in at -11 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -34 | -4.1 | -4.5 | -4.0 | -4.3 | -7.9 | -7.4 | -15 | -11 | -9.3 | -13 | -11 | -45 | |
| 3.6 | – | – | – | – | – | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| – | 0.0 | 0.0 | 0.3 | 0.3 | 0.3 | 0.4 | 0.6 | 0.6 | 0.3 | 0.6 | 0.6 | 2.2 | |
| -3.1 | -0.8 | -2.1 | -0.2 | 1.2 | -1.1 | 2.3 | -1.8 | 0.0 | 2.9 | -1.1 | -0.1 | 1.6 | |
| 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.2 | 0.0 | 0.0 | 0.0 | 0.2 | |
| -67 | – | – | – | – | – | – | – | -35 | 15 | -50 | 20 | -50 | |
| – | – | – | 5.0 | 0.0 | 10.0 | 7.5 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| – | 6.9 | 6.6 | 5.0 | 0.0 | 7.6 | 107 | 2.3 | 0.0 | 50 | 0.1 | 0.0 | 50 | |
| -101 | 2.7 | 2.1 | 1.0 | 12 | -0.3 | 100 | -13 | -46 | 56 | -64 | 8.7 | -45 | |
| -34 | -4.1 | -4.5 | -4.0 | -4.3 | -7.9 | -7.4 | -15 | -12 | -9.3 | -13 | -11 | -46 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.